Both tests employ dried blood spot testing- a method that has been used for decades by doctors and hospitals to identify disease biomarkers with only a few drops of blood-
and were developed by board-certified medical geneticists at Perkinelmer Genomics, then validated on the EUROIMMUN EUROBlotOne® system
and EUROIMMUN Analyzer™ systems.